Prostate cancer immunotherapy trial halted early: what we know
Disease control
Terminated
This early-stage trial tested an experimental immunotherapy called VTP-850 in 22 men whose prostate cancer had returned after initial treatment like surgery or radiation. The goal was to check safety and see if the treatment could lower PSA levels, a marker of cancer activity. Th…
Phase: PHASE1, PHASE2 • Sponsor: Barinthus Biotherapeutics • Aim: Disease control
Last updated May 17, 2026 02:25 UTC